Cost-Effectiveness of Tofacitinib for Patients with Moderate-to-Severe Rheumatoid Arthritis in China
Lei Tian, Xiaomo Xiong, Qiang Guo, Yixi Chen, Luying Wang, Peng Dong, Aixia Ma
Topics & Concepts
TofacitinibMedicineRheumatoid arthritisEtanerceptAdalimumabInfliximabTocilizumabInternal medicineQuality-adjusted life yearAdverse effectCost effectivenessDiseaseRisk analysis (engineering)Rheumatoid Arthritis Research and TherapiesAutoimmune and Inflammatory Disorders ResearchBiosimilars and Bioanalytical Methods